Takeda (TSE:4502/NYSE:TAK) announced the completion of the 7-year pivotal Phase 3 Tetravalent Immunization against Dengue Efficacy Study (TIDES) trial evaluating its dengue vaccine, QDENGA®▼(Dengue ...
Newspoint on MSN
AI Courses: These are the top 5 AI courses that will increase your salary in minutes..
Artificial intelligence is one of the fastest-growing and highest-paying fields today. The continued digitization of ...
How-To Geek on MSN
I Use Python, but I’m Learning R and the Tidyverse for Data Analysis Too
I 'm a big fan of Python for data analysis, but even I get curious about what else is available. R has long been the go-to ...
Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback